Eldon C. Mayer III - Mar 17, 2023 Form 4 Insider Report for Eiger BioPharmaceuticals, Inc. (EIGR)

Signature
/s/ Eldon C. Mayer III
Stock symbol
EIGR
Transactions as of
Mar 17, 2023
Transactions value $
-$4,704
Form type
4
Date filed
3/21/2023, 09:00 PM
Previous filing
Mar 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EIGR Common Stock Sale -$2.7K -2.52K -4.17% $1.07 57.9K Mar 17, 2023 Direct F1
transaction EIGR Common Stock Sale -$2.01K -1.88K -3.24% $1.07 56.1K Mar 17, 2023 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold by the reporting person in a pre-elected sell-to-cover transaction to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units ("RSUs") granted on March 11, 2022 for 16,000 shares.
F2 These shares were sold by the reporting person in a pre-elected sell-to-cover transaction to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 12, 2021 for 11,875 shares.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.07 to $1.08, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.